US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

240.37

+2.921.23%

Post-market: 240.530.1607+0.07%16:10 EDT

Volume:9K

Turnover:2.23M

Market Cap:482.30M

PE:- -

High:240.71

Open:236.99

Low:236.64

Close:237.45

52wk High:246.55

52wk Low:171.63

Shares:2.01M

Float Shares:2.01M

Volume Ratio:0.84

T/O Rate:0.47%

Dividend:0.95

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015

Vertex Pharmaceuticals announces positive results from Phase 2b inaxaplin study

Vertex Says Phase 2b Amplified Study Shows Inaxaplin Cuts Proteinuria in APOL1-Mediated Kidney Disease Patients with Modest Proteinuria

Vertex Pharmaceuticals Incorporated - Inaxaplin Reduces Uacr by -42.7% at Week 13 in Amkd with Modest Proteinuria

THOMSON REUTERS

Vertex Pharmaceuticals Incorporated - Inaxaplin Generally Safe and Well Tolerated in Both Amkd Cohorts

THOMSON REUTERS

Vertex Announces Positive Results from Phase 2B Amplified Study of Inaxaplin in Additional Populations of People with Apol1-Mediated Kidney Disease (Amkd) and Completion of Enrollment in the Phase 2/3 Amplitude Trial

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)

Sino Biopharmaceutical Stock Slips 1.4% in Hong Kong, Underperforms Competitors

Nvidia, QIA-Backed Iambic Therapeutics Files for US IPO as Biotech Boom Rolls On

Moderna Inc. Stock Climbs 12.3%, Outperforms Peers

Vertex Pharmaceuticals Incorporated : Leerink Partners Resumes Coverage with Outperform Rating; Target Price $594

THOMSON REUTERS

Sino Biopharmaceutical Stock Rises 8.2% in Hong Kong, Outperforms Competitors

Correction to Vertex Material Listing Article on Sept. 17

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Vertex wins approval for 24/7 underground operations at Reward Gold Mine

Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BBH/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":240.3709,"timestamp":1791230400000,"preClose":237.4531,"halted":0,"volume":9365,"hourTrading":{"tag":"盘后","latestPrice":240.5316,"preClose":240.3709,"latestTime":"16:10 EDT","volume":23,"amount":5532.31075,"timestamp":1791231005843,"change":0.1607,"changeRate":0.000669,"amplitude":0.000035},"delay":0,"changeRate":0.012287900221138404,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"Post-Mkt","change":2.9178,"latestTime":"10-05 16:14:32 EDT","open":236.99,"high":240.705,"low":236.6444,"amount":2231953.3326,"amplitude":0.017101,"askPrice":326.44,"askSize":100,"bidPrice":186.37,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791244800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":237.4531,"sharesOutstanding":1976503,"nav":237.39591,"aum":476335613.78,"dividendRate":0.003951,"bidAskSpread":0.001118,"postHourTrading":{"tag":"盘后","latestPrice":240.5316,"preClose":240.3709,"latestTime":"16:10 EDT","volume":23,"amount":5532.31075,"timestamp":1791231005843,"change":0.1607,"changeRate":0.000669,"amplitude":0.000035},"volumeRatio":0.837821,"impliedVol":0.2044,"impliedVolPercentile":0.6454},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2006503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.837821,"shares":2006503,"dividePrice":0.9498,"high":240.705,"amplitude":0.017101,"preClose":237.4531,"low":236.6444,"week52Low":171.63,"pbRate":"--","week52High":246.55,"institutionHeld":0,"latestPrice":240.3709,"eps":0,"divideRate":0.003951,"volume":9365,"delay":0,"ttmEps":0,"open":236.99,"prevYearClose":189.2649,"prevWeekClose":237.4531,"prevMonthClose":244.575,"prevQuarterClose":244.575,"fiveDayClose":245.3373,"twentyDayClose":241.1222,"sixtyDayClose":205.546},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669144047","title":"Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144047","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144047?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:30","pubTimestamp":1790080200,"startTime":"0","endTime":"0","summary":"New Preclinical PDAC Package for PRP Shows >90% Tumor-Growth Inhibition & >2.5-Fold Survival Benefit; Company Contrasts Mechanism, Breadth, & Development Role Against Erasca’s Phase 1 ERAS-0015 Datase","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366329/0/en/propanc-biopharma-highlights-differentiated-prp-pancreatic-cancer-data-versus-emerging-pan-ras-program-eras-0015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0724618433.USD","LU1861220033.SGD","BK4548","BBH","01698","BK4141","BK4571","PDX","BK4585","LU0109394709.USD","LU0269904917.USD","BK4535","IE00BYTNYN87.SGD","LU0359202008.SGD","LU1861219969.SGD","BK4139","BK4509","LU1548497426.USD","IE00B12V2V27.USD","LU1720051017.SGD","BK4108","BK4588","ONG","LU1023057109.AUD","PPCB","SG9999011746.SGD","CANC","BK4531","IE00BJT1NW94.SGD","LU1854103824.USD","LU1854104046.USD","BK4512","TME","PTH","ONX","BK4565","IDNA","RVMD","ERAS","IE0009354923.USD","LU0320765992.SGD","LU0509642566.USD","BK4605","LU2357305700.SGD","ON","LU2360107325.USD","LU2298322129.HKD","IE00BFTCPJ56.SGD","IE00BYQNZ168.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144313","title":"Vertex Pharmaceuticals announces positive results from Phase 2b inaxaplin study","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144313","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144313?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:15","pubTimestamp":1790079331,"startTime":"0","endTime":"0","summary":"The company states: “Vertex Pharmaceuticals (VRTX) announced positive results from the Phase 2b AMPLIFIED study of inaxaplin in people with APOL1-m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-announces-positive-results-from-phase-2b-inaxaplin-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-announces-positive-results-from-phase-2b-inaxaplin-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1430594728.SGD","IE00B19Z3B42.SGD","IE00B19Z9Z06.USD","LU0432979614.USD","IE0009355771.USD","LU0109394709.USD","LU0061475181.USD","LU2362540622.SGD","LU2462157665.USD","TBXU","BK4567","LU1093756325.SGD","LU0320765992.SGD","LU2236285917.USD","LU2237438978.USD","LU1093756168.USD","IBBQ","LU1585245621.USD","LU0289739699.SGD","IDNA","IE00B2B36J28.USD","VERX","GNMX","LU0823416689.USD","IE0002141913.USD","BK4023","LU0757428866.USD","BK4139","LU1674673428.USD","BIB","LU0234570918.USD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","BK4532","IE00BFTCPJ56.SGD","LU1035775433.USD","LU1674673691.USD","IBB","LU1815336091.USD","SG9999001176.SGD","BBH","IE00BJT1NW94.SGD","LU0256863811.USD","BK4588","VRTX","LU1778281490.HKD","PBE","LU2089984988.USD","SG9999013999.USD","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669177141","title":"Vertex Says Phase 2b Amplified Study Shows Inaxaplin Cuts Proteinuria in APOL1-Mediated Kidney Disease Patients with Modest Proteinuria","url":"https://stock-news.laohu8.com/highlight/detail?id=2669177141","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669177141?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:02","pubTimestamp":1790078577,"startTime":"0","endTime":"0","summary":"Vertex says Phase 2b AMPLIFIED study shows inaxaplin cuts proteinuria in APOL1-mediated kidney disease patients with modest proteinuriaVertex reported positive Phase 2b AMPLIFIED results for inaxaplin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL8CHhBr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","IBBQ","TBXU","IE00B19Z9P08.USD","LU0889565916.HKD","LU0823416689.USD","IE0002141913.USD","BK4532","PBE","LU0320765992.SGD","IE00BJT1NW94.SGD","IDNA","VRTX","BBH","LU1674673428.USD","BK4567","LU2462157665.USD","LU0061475181.USD","LU0109394709.USD","LU1035775433.USD","LU1069344957.HKD","LU2362541513.USD","IE00B2B36J28.USD","LU1093756325.SGD","LU0058720904.USD","LU0256863811.USD","IBB","BK4585","LU0079474960.USD","LU2089984988.USD","LU2468319806.SGD","IE00B19Z3581.USD","BIB","LU0432979614.USD","LU1093756168.USD","BK4588","SG9999013999.USD","IE00BFTCPJ56.SGD","LU1674673691.USD","BK4139","IE0002270589.USD","IE00B19Z9Z06.USD","GNMX","SG9999001176.SGD","LU2237438978.USD","SGXZ57979304.SGD","IE0009355771.USD","LU2362541273.HKD","IE00BZ9MQY76.HKD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669419861","title":"Vertex Pharmaceuticals Incorporated - Inaxaplin Reduces Uacr by -42.7% at Week 13 in Amkd with Modest Proteinuria","url":"https://stock-news.laohu8.com/highlight/detail?id=2669419861","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669419861?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA6RPXRQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","LU0234570918.USD","LU0109394709.USD","BK4139","IE00B2B36J28.USD","LU2236285917.USD","BK4585","LU1430594728.SGD","IE00B4R5TH58.HKD","LU1069344957.HKD","SG9999001176.SGD","LU0079474960.USD","LU2362540622.SGD","IDNA","IE0002141913.USD","LU0256863811.USD","LU2468319806.SGD","IE00B19Z9P08.USD","TBXU","LU1778281490.HKD","LU2456880835.USD","IE0002270589.USD","LU1093756325.SGD","LU2462157665.USD","LU0417517546.SGD","LU2417539215.USD","SGXZ57979304.SGD","BIB","IBB","IE00BJT1NW94.SGD","IE00B894F039.SGD","LU0823416689.USD","IE00B19Z9Z06.USD","IBBQ","LU1674673691.USD","IE0009355771.USD","LU0289739699.SGD","GNMX","LU2237438978.USD","VRTX","LU2362541273.HKD","LU1585245621.USD","LU1674673428.USD","LU0889565916.HKD","LU2362541513.USD","PBE","IE00B19Z3581.USD","LU1093756168.USD","IE00BJJMRZ35.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669419041","title":"Vertex Pharmaceuticals Incorporated - Inaxaplin Generally Safe and Well Tolerated in Both Amkd Cohorts","url":"https://stock-news.laohu8.com/highlight/detail?id=2669419041","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669419041?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA6RPXRQ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","LU0432979614.USD","IE00BZ9MQY76.HKD","SG9999001176.SGD","LU0256863811.USD","VRTX","LU0889565916.HKD","LU2362541273.HKD","LU1035775433.USD","LU1069344957.HKD","BBH","BK4139","LU0320765992.SGD","LU1674673428.USD","PBE","LU0058720904.USD","BK4532","IE00BJJMRZ35.SGD","SG9999013999.USD","BK4567","LU0234570918.USD","IE00B19Z9P08.USD","LU2089984988.USD","BIB","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","LU0061475181.USD","SGXZ57979304.SGD","LU2324357040.USD","IE0002141913.USD","LU0079474960.USD","BK4533","IBB","LU2362541513.USD","TBXU","IBBQ","IE0002270589.USD","LU1778281490.HKD","IDNA","BK4588","GNMX","LU2456880835.USD","BK4585","SG9999001176.USD","LU0109394709.USD","LU1585245621.USD","LU2417539215.USD","LU1093756325.SGD","LU2237438978.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141954","title":"Vertex Announces Positive Results from Phase 2B Amplified Study of Inaxaplin in Additional Populations of People with Apol1-Mediated Kidney Disease (Amkd) and Completion of Enrollment in the Phase 2/3 Amplitude Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141954","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141954?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA6RPXRQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001176.SGD","IBBQ","IE00B19Z3581.USD","BK4532","LU1778281490.HKD","IE00BJT1NW94.SGD","LU0417517546.SGD","BK4585","LU1035775433.USD","LU1069344957.HKD","LU0058720904.USD","LU0432979614.USD","LU0061475181.USD","SGXZ57979304.SGD","SG9999001176.USD","LU1674673428.USD","LU0234570918.USD","LU0256863811.USD","BK4139","IE00BZ9MQY76.HKD","BK4533","LU0823416689.USD","LU2456880835.USD","SG9999013999.USD","LU1093756325.SGD","BBH","IE00B19Z3B42.SGD","TBXU","VRTX","LU1585245621.USD","LU0889565916.HKD","IE0002270589.USD","LU0320765992.SGD","PBE","LU0079474960.USD","IE0002141913.USD","GNMX","BIB","IE00B19Z9P08.USD","LU0109394709.USD","IBB","BK4567","LU1674673691.USD","LU2237438978.USD","LU0289739699.SGD","LU2089984988.USD","LU2236285917.USD","IE00B4R5TH58.HKD","IDNA","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143096","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143096?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:10","pubTimestamp":1790071809,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA). ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-invivyd-ivvd-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-invivyd-ivvd-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1983299246.USD","TBXU","LU2468319806.SGD","IE00BJT1NW94.SGD","IVVD","BK4563","PBE","LU1057294990.SGD","LU2089984988.USD","LU2242652126.USD","LU1061106388.HKD","BK4539","LU1571399168.USD","IE0009355771.USD","BK4599","LU0128526141.USD","LU0868494617.USD","LU0029874061.USD","BK4533","BK4585","HCSG","AMGN","XBI","BK4139","IE00BFTCPJ56.SGD","IBBQ","BIB","BK4137","LU0289739699.SGD","LU0889565916.HKD","LU0122379950.USD","XLV","LU1023059063.AUD","IE00BJJMRZ35.SGD","PJP","BK4534","IBB","HUMA","LU0058720904.USD","LU2242646821.SGD","BK4588","LABU","BBH","BK4566","IE0002141913.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669511784","title":"Sino Biopharmaceutical Stock Slips 1.4% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669511784","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669511784?lang=en_us&edition=fundamental","pubTime":"2026-09-22 16:32","pubTimestamp":1790065920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.4% to 5.84 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.2% to 25087.75.Sino Biopharmaceutical Ltd. closed 32% short of its 52-week high of HK$8.56, which the company reached Sept. 23.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.1% and Amgen Inc. remained unchanged.Trading volume totaled 87.2 million shares, compared to the 50-day average of 88.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","LU1057294990.SGD","BK4588","BK4581","LU2112291526.USD","BK4139","IE00B2B36J28.USD","BK4599","IE00B4R5TH58.HKD","BK1589","PJP","LU0109394709.USD","BIB","HK0000165453.HKD","LU1061106388.HKD","BK1515","BK4585","LU2089984988.USD","BK1521","IE00BJT1NW94.SGD","TBXU","BK4566","01177","BK1191","BK4533","IE0009355771.USD","LU0320765992.SGD","LU1571399168.USD","LU2242652126.USD","LU0889565916.HKD","AMGN","IBB","IE0002141913.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE00BZ08YT58.USD","LU1983299246.USD","BBH","IE00BZ08YR35.GBP","BK4534","LU0289739699.SGD","LU2242646821.SGD","IE00BZ08YS42.EUR","LU1023059063.AUD","LU0122379950.USD","LU0058720904.USD","PBE","IBBQ","SG9999001440.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669193392","title":"Nvidia, QIA-Backed Iambic Therapeutics Files for US IPO as Biotech Boom Rolls On","url":"https://stock-news.laohu8.com/highlight/detail?id=2669193392","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669193392?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:38","pubTimestamp":1790023092,"startTime":"0","endTime":"0","summary":"UPDATE 3-Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls onSept 21 (Reuters)-Drug developer Iambic Therapeutics, backed by chip giant NvidiaNVDA.Oand Qatar's sovereign we","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D1EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTE","PJP","VGT","NVDA","BBH","RXL","NVDO","USD","PPH","CLSE","NVII","FDTX","SNPE","SOXQ","TEK","GAMR","ABFL","07388","NVDG","CHPX","UYG","BAC","CMAG","SOXY","ABBV","FHLC","SHOC","TFNS","CHAT","09388","3NVD.UK","RVMD","07788","SNVD.UK","SOXX","AIPI","ARTY","CANC","JAZZ","JGRO","VHT","ESLG","2NVD.UK","VT","CNEQ","DIPS","JDOC","LFGY","NVDS.UK","XLF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669619383","title":"Moderna Inc. Stock Climbs 12.3%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2669619383","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669619383?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:33","pubTimestamp":1790022780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. jumped 12.3% to $172.94 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.3% to 27,122.09 and the Dow Jones Industrial Average rising 0.7% to 52,048.83.Moderna Inc. closed 2.1% short of its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.2% to $269.47, Pfizer Inc. rose 0.3% to $27.74, and Gilead Sciences Inc. rose 0.30% to $150.56.Trading volume totaled 20.9 million, compared to the 50-day average of 17.9 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","TBXU","LU0889565916.HKD","WDNA","BK4532","LU0320765992.SGD","BK4533","IDNA","BBH","LU1674673428.USD","BMED","LU0109394709.USD","BK4501","LGHT","LU0234570918.USD","LU1839511570.USD","LU1066051498.USD","LU1778281490.HKD","IE00BSNM7G36.USD","LU0882574055.USD","LU1934455194.USD","IE00B7SZLL34.SGD","MRNX","LU0058720904.USD","MRNA","IBB","BK4534","LU2089984988.USD","LU2468319806.SGD","GILD","LU1430594728.SGD","BIB","LU0965509101.SGD","SG9999015952.SGD","LU1066053197.SGD","MEDI","LU0289739699.SGD","BK4548","BK4139","BK4578","IE0002270589.USD","LU0859254822.USD","TMED","LU0122379950.USD","LU0861579265.USD","LU1061106388.HKD","SG9999015986.USD","GNOM","MRNY","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669315293","title":"Vertex Pharmaceuticals Incorporated : Leerink Partners Resumes Coverage with Outperform Rating; Target Price $594","url":"https://stock-news.laohu8.com/highlight/detail?id=2669315293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669315293?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:03","pubTimestamp":1789985027,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45A0U1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBB","IE00BZ9MQY76.HKD","IE0009355771.USD","LU1674673428.USD","IE00B19Z9P08.USD","IE00B19Z3581.USD","LU2362541273.HKD","LU2236285917.USD","LU2468319806.SGD","LU0109394709.USD","BK4532","LU2089984988.USD","BBH","BK4139","BK4567","LU0256863811.USD","LU1778281490.HKD","TBXU","LU0061475181.USD","LU0823416689.USD","SG9999013999.USD","LU1585245621.USD","IDNA","LU2417539215.USD","IE00BJJMRZ35.SGD","LU0234570918.USD","IE00BFTCPJ56.SGD","GNMX","PBE","LU1069344957.HKD","IE00BJT1NW94.SGD","LU1093756168.USD","BK4533","LU1093756325.SGD","LU2324357040.USD","LU2362540622.SGD","LU2462157665.USD","LU1035775433.USD","IE00B894F039.SGD","LU0058720904.USD","IBBQ","SG9999001176.SGD","VRTX","BIB","BK4588","IE00B4R5TH58.HKD","LU0289739699.SGD","LU0320765992.SGD","LU2362541513.USD","LU2456880835.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669156720","title":"Sino Biopharmaceutical Stock Rises 8.2% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669156720","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669156720?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:30","pubTimestamp":1789979400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 8.2% to 5.92 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.2% to 25042.71.Sino Biopharmaceutical Ltd. closed 32% below its 52-week high of HK$8.65, which the company achieved Sept. 22.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 7.6% and Amgen Inc. remained unchanged.Trading volume totaled 150.2 million shares, compared to the 50-day average of 89.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00BZ08YR35.GBP","BK1589","BK1521","BK4599","LU1983299246.USD","LU0058720904.USD","BBH","IE00BFTCPJ56.SGD","BK4588","BK1191","01177","AMGN","BK1515","IE0002141913.USD","IE00B2B36J28.USD","LU2242646821.SGD","PJP","LU2242652126.USD","LU2468319806.SGD","LU0109394709.USD","IE00B4R5TH58.HKD","BK4533","IE00BZ08YS42.EUR","IBB","BK4566","LU0289739699.SGD","BK4585","TBXU","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0122379950.USD","IBBQ","LU1061106388.HKD","LU2089984988.USD","IE00BZ08YT58.USD","SG9999001440.SGD","LU0889565916.HKD","LU1571399168.USD","LU2112291526.USD","IE00BJJMRZ35.SGD","BK4534","PBE","LU0320765992.SGD","BK4139","LU1023059063.AUD","LU0868494617.USD","BK4581","HK0000165453.HKD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669412132","title":"Correction to Vertex Material Listing Article on Sept. 17","url":"https://stock-news.laohu8.com/highlight/detail?id=2669412132","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669412132?lang=en_us&edition=fundamental","pubTime":"2026-09-21 12:48","pubTimestamp":1789966080,"startTime":"0","endTime":"0","summary":"Tan Chin Teong is the founder and technical director of Vertex Material. \"Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing,\" at 0931 GMT on Sept. 17, misstated the name as Tan Chin Tong.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462157665.USD","IDNA","SG9999001176.SGD","VERX","LU1093756325.SGD","TBXU","LU2362541513.USD","BK4588","IE00B2B36J28.USD","LU0417517546.SGD","IE00B4R5TH58.HKD","IBB","LU2468319806.SGD","LU0256863811.USD","LU1093756168.USD","LU1035775433.USD","LU2089984988.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU0566484027.USD","LU0823416689.USD","LU2362541273.HKD","PBE","BK4023","BBH","GNMX","BIB","IE00B19Z9Z06.USD","LU2324357040.USD","LU0079474960.USD","LU2236285917.USD","LU0889565916.HKD","LU2362540622.SGD","VRTX","LU0234570918.USD","IE00B19Z3B42.SGD","SG9999001176.USD","BK4567","LU0109394709.USD","LU1585245621.USD","LU0320765992.SGD","SG9999013999.USD","IE00B19Z9P08.USD","LU0058720904.USD","IE00BJJMRZ35.SGD","LU0757428866.USD","IBBQ","IE00B894F039.SGD","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973164","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973164","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973164?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:34","pubTimestamp":1789763640,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rallied 1.55% to $385.65 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.17% to 7,650.50 and the Dow Jones Industrial Average  falling 0.18% to 51,682.64.This was the stock's third consecutive day of gains.Amgen Inc. closed 13.73% below its 52-week high of $447.03, which the company reached on August 25th.The stock outperformed some of its competitors Friday, as Johnson & Johnson  fell 0.09% to $269.99, Pfizer Inc.  rose 0.07% to $27.66, and AbbVie Inc.  fell 0.02% to $263.96.Trading volume  eclipsed its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 18, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4534","BBH","IBBQ","IE00B2B36J28.USD","LU2242646821.SGD","LU0122379950.USD","PBE","BK4139","IE00BJJMRZ35.SGD","LU2112291526.USD","IBB","BK4588","LU1061106388.HKD","SG9999001440.SGD","TBXU","IE0002141913.USD","LU0320765992.SGD","BK4585","LU0889565916.HKD","LU0058720904.USD","LU2242652126.USD","BK4581","PJP","IE0009355771.USD","BK4599","BIB","LU1571399168.USD","LU1983299246.USD","LU0868494617.USD","LU1023059063.AUD","LU2089984988.USD","LU0289739699.SGD","LU2468319806.SGD","LU1057294990.SGD","BK4566","IE00B4R5TH58.HKD","AMGN","BK4533","IE00BFTCPJ56.SGD","04332","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668914913","title":"Vertex wins approval for 24/7 underground operations at Reward Gold Mine","url":"https://stock-news.laohu8.com/highlight/detail?id=2668914913","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668914913?lang=en_us&edition=fundamental","pubTime":"2026-09-18 08:18","pubTimestamp":1789690694,"startTime":"0","endTime":"0","summary":"An announcement from Vertex Minerals Ltd. ( ($AU:VTX) ) is now available. Vertex Minerals has secured a varied Environment Protection License from ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z9Z06.USD","LU1778281490.HKD","IDNA","IE0009355771.USD","VRTX","IE00BZ9MQY76.HKD","LU1069344957.HKD","LU2468319806.SGD","LU2362541513.USD","IBBQ","BK4585","IE00B894F039.SGD","IE0002270589.USD","LU2362540622.SGD","BK4533","BK4139","LU2089984988.USD","LU1674673691.USD","SGXZ57979304.SGD","LU0432979614.USD","TBXU","BIB","LU0058720904.USD","IE00B19Z9P08.USD","BK4532","BBH","BK4567","IBB","LU0889565916.HKD","LU1035775433.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","SG9999013999.USD","LU1559883803.SGD","LU2236285917.USD","LU0757428866.USD","VERX","LU0079474960.USD","IE0002141913.USD","SG9999001176.SGD","LU1815336091.USD","LU2237438978.USD","LU0289739699.SGD","LU2324357040.USD","PBE","SG9999001176.USD","IE00BJT1NW94.SGD","LU0109394709.USD","GNMX","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668990195","title":"Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2668990195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668990195?lang=en_us&edition=fundamental","pubTime":"2026-09-18 06:33","pubTimestamp":1789684401,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has provided an announcement. Vortex Energy Corp. has entered into an asset purchase agreement to acquire the M...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","LU1585245621.USD","BK4585","SG9999013999.USD","LU2362541513.USD","LU0109394709.USD","GNMX","IE00B2B36J28.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","LU2237438978.USD","SG9999001176.SGD","LU0432979614.USD","IDNA","LU0823416689.USD","IE00BJT1NW94.SGD","IE00B19Z3B42.SGD","LU2468319806.SGD","BBH","VRTX","BK4588","LU2362541273.HKD","LU0079474960.USD","SGXZ57979304.SGD","BK4532","IE0002270589.USD","IE00B19Z9Z06.USD","LU0417517546.SGD","BIB","PBE","TBXU","LU2417539215.USD","IBBQ","LU0061475181.USD","LU0058720904.USD","BK4567","LU2456880835.USD","SG9999001176.USD","LU1674673428.USD","LU2462157665.USD","IE00BFTCPJ56.SGD","BK4139","IE00BZ9MQY76.HKD","LU1093756325.SGD","LU1430594728.SGD","LU2236285917.USD","IE00B894F039.SGD","LU0256863811.USD","LU1069344957.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992198","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992198","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992198?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:34","pubTimestamp":1789677240,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rose 2.17% to $150.89 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.14% to 7,637.76 and the Dow Jones Industrial Average  rising 0.61% to 51,778.04.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 4.07% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  rose 1.10% to $270.22, Pfizer Inc.  rose 0.66% to $27.64, and Abbott Laboratories  fell 0.13% to $102.23.Trading volume  eclipsed its 50-day average volume of 6.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 17, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455277.USD","SG9999015952.SGD","IBB","IE00BZ1G4Q59.USD","LU1674673691.USD","BK4578","LU0122379950.USD","LU0882574055.USD","LU2112291526.USD","BMED","LU0234570918.USD","LU1037948541.HKD","LU0823416689.USD","BK4566","LU0114720955.EUR","LU0289739699.SGD","LU1585245621.USD","LU1066051498.USD","LU1839511570.USD","TMED","LU1066053197.SGD","LU1571399168.USD","SG9999015978.USD","LU2468319806.SGD","IE00BKVL7J92.USD","BK4532","LU1674673428.USD","LU2089984988.USD","LU2357627491.SGD","IE00B19Z3581.USD","IE0002270589.USD","LU0109394709.USD","LU1778281490.HKD","BK4583","MEDI","LU1057294990.SGD","LU0965509283.SGD","BK4585","LU1061106388.HKD","IE00B3T34201.USD","BK4139","LU1037948897.HKD","LU0320765992.SGD","LU2324357040.USD","LU1934455194.USD","GILD","LU0058720904.USD","IE00BSNM7G36.USD","LU0859254822.USD","LU0889565916.HKD","LU0965509101.SGD","BIB","IE00B7SZLL34.SGD","LU0861579265.USD","BBH","BK4588","IE00B19Z3B42.SGD","BK4568","LU1430594728.SGD","BK4550","LU0965508806.USD","LU1934455863.HKD","SG9999015986.USD","LU1023059063.AUD","SG9999015945.SGD","LU0965509010.AUD","TBXU","IBBQ","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992940","title":"Moderna Inc. Stock Climbs 8.5%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992940","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992940?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:33","pubTimestamp":1789677180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 8.5% to $158.07 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.7% to 26,418.30 and the Dow Jones Industrial Average rising 0.6% to 51,778.04.This was the stock's second consecutive day of gains.Moderna Inc. closed 10.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.22, Pfizer Inc. rose 0.7% to $27.64, and Gilead Sciences Inc. rose 2.17% to $150.89.Trading volume totaled 19.1 million, compared to the 50-day average of 17.3 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","MRNA","SG9999015986.USD","TMED","LU0965509010.AUD","LU0861579265.USD","LU0234570918.USD","LU0889565916.HKD","IDNA","LU0320765992.SGD","WDNA","MEDI","LU0882574055.USD","BBH","LU0289739699.SGD","MRNY","BK4568","IE00B7SZLL34.SGD","LU1037948897.HKD","LU1585245621.USD","LU0859254822.USD","LU2324357040.USD","GNOM","LU1778281490.HKD","BK4534","IE00B19Z3581.USD","MRNX","TBXU","BK4501","LU2357627491.SGD","BK4566","GILD","IE00BZ1G4Q59.USD","LU1839511570.USD","BK4578","BK4551","LU0823416689.USD","LU0965509101.SGD","IE00BSNM7G36.USD","SG9999015945.SGD","LU1061106388.HKD","LU1934455863.HKD","LU1674673428.USD","BMED","LU0114720955.EUR","LGHT","LU2089984988.USD","BIB","LU0122379950.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668993629","title":"Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668993629","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668993629?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662630,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is running a Phase 3 study testing romiplostim plus predni...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1057294990.SGD","BK4534","IE00BJJMRZ35.SGD","BBH","PBE","BK4199","LU0320765992.SGD","BK4599","LU0122379950.USD","LU0889565916.HKD","LU0868494617.USD","BK4585","BIB","LU1983299246.USD","BK4581","SG9999001440.SGD","IE0009355771.USD","IE0002141913.USD","LU0058720904.USD","IBB","AMGN","IE00B2B36J28.USD","IBBQ","LU2112291526.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","BK4588","IE00BFTCPJ56.SGD","BK4566","ITP","LU0289739699.SGD","IE00BJT1NW94.SGD","PJP","LU2242646821.SGD","LU2242652126.USD","LU1061106388.HKD","LU2089984988.USD","LU2468319806.SGD","BK4533","TBXU","LU0109394709.USD","LU1571399168.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668962770","title":"Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668962770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668962770?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:40","pubTimestamp":1789648810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Charles River Labs (CRL) and Amgen (AMGN) with bulli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","LU0868494617.USD","LU0058720904.USD","BK4139","IE00B2B36J28.USD","BK4585","LU1057294990.SGD","IE00BFMHRM44.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU1815336091.USD","BK4599","BK4581","LU1983299246.USD","LU0757428866.USD","AMGN","SG9999001440.SGD","BK4588","IE0002141913.USD","LU0390134368.USD","BK4530","LU1061106388.HKD","LU2468319806.SGD","TBXU","LU0029874061.USD","BK4533","HCSG","LABU","BK4121","LU2112291526.USD","LU2089984988.USD","PJP","BIB","IBB","IE00BJT1NW94.SGD","LU2242646821.SGD","LU0122379950.USD","BK4137","BK4566","IBBQ","LU0128526141.USD","IE0009355771.USD","LU0289739699.SGD","CRL","XLV","XBI","LU0889565916.HKD","PBE","IE00BJJMRZ35.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}